1. SWOT Analysis
  2. Healthcare
  3. Daiichi Sankyo SWOT Analysis

Daiichi Sankyo SWOT Analysis

Published by MBA Skool Team in Pharma and Healthcare category Last Updated: May 24, 2024Read time:

Here is a detailed SWOT analysis of Daiichi Sankyo covering strengths, weaknesses, opportunities and threats.

Daiichi Sankyo Strengths

  1. Has a strong workforce of over 30,000 employees
  2. Leading producer of Benicar which is angiotensin II receptor antagonist
  3. It is one of the largest pharmaceutical company in Japan
  4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others
  5. Strong brand establishment through many major acquisitions

Above are the strengths in the SWOT Analysis of Daiichi Sankyo. The strengths of Daiichi Sankyo looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Daiichi Sankyo Weaknesses

  1. Despite being a strong brand, had a limited market share due to international competitors
  2. Operates in limited segments such as Oncology & Cardiovascular segment

These were the weaknesses in the Daiichi Sankyo SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Daiichi Sankyo Opportunities

  1. Increasing world population and more awareness about health
  2. More people suffering from chronic diseases such as cancer, cardiovascular diseases
  3. Increasing awareness of healthcare solutions

Above we covered the opportunities in Daiichi Sankyo SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Daiichi Sankyo Threats

  1. Natural disasters in Japan
  2. increasing stringency in drug development guidelines
  3. Global economic slowdown

The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Daiichi Sankyo SWOT analysis.

Read Similar SWOT analysis

About Daiichi Sankyo

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Daiichi Sankyo Overview
Parent Company

Daiichi Sankyo




Pharma and Healthcare

Tagline/ Slogan

Passion for innovation, Compassion for patients


It is one of the largest pharmaceutical company in Japan

Daiichi Sankyo STP

Oncology & Cardiovascular diseases

Target Group

Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease


They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time

This article has been researched & authored by the Content & Research Team which comprises of MBA students, management professionals, and industry experts. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin